Stock screener

INCY

Conviction 80HealthcareScan · Mon, Aug 10, 2026
INCY$121.60+0.86%
ResistanceSupportVol 14Insider sellCongress buyCongress sell
63 bars
2
Vol MA14 2.13M
May 11May 28Jun 16Jul 6Jul 23Aug 10
INCYTE CORPSERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCHwww.incyte.com ↗
Price121.60
Change+0.86%
Gap+0.05%
Rel volume0.72×
Avg volume1.97M
Avg $ vol238.51M
SMA 20119.24
SMA 50111.85
SMA 200102.24
Price vs 50+8.71%
Price vs 200+18.93%
MA stackbullish
50/200 cross—
Supertrendup · 114.69
RSI (14)57
MACD hist-0.55
MACD crossbear · 5d
Stoch %K / %D39 / 31
ADX (14)25
+DI / −DI30 / 21
RSI divergence—
MACD divergenceBearish
ATR %+3.35%
ADR %3.46%
52w high129.93
52w low78.39
From 52w high-6.41%
Above 52w low+55.12%
New 52w highNo
SqueezeOff
Bollinger width12.67%
%B0.66
Donchian pos50.07%
Donchian high132.60
Donchian low110.56
AVWAP (52w high)123.00
vs AVWAP high-1.14%
AVWAP (52w low)99.20
vs AVWAP low+22.57%
OBV trendUp
Chaikin MF (20)0.05
Today vs 20d0.72×
Avg vol (14d)2.13M
Avg vol (20d)1.97M
Avg $ vol (20d)238.51M
Market cap—
RS 3m (vs SPY)+17.61%
RS 6m (vs SPY)+3.21%
RS line new highNo
Trend template8/8
Technical rank78.1
1 week+2.67%
1 month+4.19%
3 months+23.37%
6 months+12.18%
1 year+55.49%
YTD+19.89%
P/E18.73
P/B4.29
P/S4.69
P/FCF17.65
EPS6.41
Div yield—
ROE22.88%
ROA17.53%
Debt/Eq0.18
Current3.68
EV/EBITDA13.46
Gross margin—
Net margin25.03%
Rev growth21.22%
EPS growth3844.96%
Price target129.94
Target upside7.74%
Analyst ratingBuy
Institutional111.64%
Ent. value21.64B
Revenue1.27B
Net income303.33M
Gross profit—
Free cash flow1.36B
IndustrySERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
ExchangeNasdaq
Shares out199.78M
Employees2.84K
ListedWed, Nov 3, 1993
Free float—
Float %—
Short interest—
Days to cover—
Short volume—
Squeeze score—
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeA
Conviction80 / 100
Pattern quality—
Tech rank78.1 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance128.59
Support103.33
Days since event—
Candle confirm—
News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in INCY · 1 recent

All disclosures →
MemberSideAmount
Rob Bresnahan
Rob Bresnahan
house · PA · traded 2025-05-15
Sell$1K–$15K

Insider activity

SEC Form 4 transactions in INCY · 5 buys · 5 sells

InsiderSideShares
CAGNONI PABLO J
President, Global Head of R&D · Common Stock · 2026-08-05
Sell10.64K
Mayes Patrick A
EVP & Chief Scientific Officer · Employee Stock Option (right to buy) · 2026-08-05
Exercise2.21K
Mayes Patrick A
EVP & Chief Scientific Officer · Common Stock · 2026-08-05
Sell2.21K
Mayes Patrick A
EVP & Chief Scientific Officer · Common Stock · 2026-08-05
Exercise2.21K
Morrissey Michael James
EVP, Head of Tech. Operations · Performance Shares · 2026-07-23
Grant9K
Heeson Lee
EVP, Head of Incyte Intl · Performance Shares · 2026-07-23
Grant13.5K
Heeson Lee
EVP, Head of Incyte Intl · Employee Stock Option (right to buy) · 2026-07-23
Grant15.42K
Morrissey Michael James
EVP, Head of Tech. Operations · Employee Stock Option (right to buy) · 2026-07-23
Grant6.43K
CAGNONI PABLO J
President, Global Head of R&D · Common Stock · 2026-07-15
Tax4.95K
Stein Steven H
CMO & Head of Late-Stage Dev. · Common Stock · 2026-07-15
Sell28.24K

SEC filings

EDGAR filings in INCY · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.